Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -148.96M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,340,800
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A
AngelosProject
AngelosProject Apr. 20 at 10:27 PM
0 · Reply
AngelosProject
AngelosProject Apr. 20 at 8:31 PM
0 · Reply
MorganHoratio
MorganHoratio Apr. 18 at 12:31 PM
$KLRA: Clinical‑stage biopharma, speculative “unwritten story,” but liquidity is a risk. $AVEX: Cancer drug developer with upcoming data readouts — early pattern looks like HOOD. $NBIS: AI infrastructure play, strong narrative but fierce competition — watch for margin bottom. $HIMS: Telehealth + consumer brand, stable subs, but valuation is no longer cheap — more mid‑term hold. $ONDS: Radar/communication + defense/drone, highly volatile, event‑driven.
4 · Reply
NasdaqPulse
NasdaqPulse Apr. 18 at 12:20 PM
I called $HOOD early as the next big momentum play — and I’m not slowing down. Still scanning for asymmetric setups with real upside. 👉Click to view @NasdaqPulse for timely updates amid the volatility. Here’s what’s on my radar right now: $KLRA — clinical-stage biotech, low float, high speculation. Story not priced in yet, but liquidity = risk. $AVEX — oncology pipeline + upcoming catalysts. Tape starting to resemble early $HOOD-type accumulation. $NBIS — AI infra theme still hot. Strong narrative, but margins + competition = key variables. Watching closely. HIMS — clean execution, strong subs growth. Not cheap anymore → more of a swing/position trade. ONDS — defense + drone tech. Violent moves, pure event-driven name. I’m hunting for the next 5–10x before the crowd sees it. One name is standing out — will drop it soon. Stay early or stay chasing.
0 · Reply
STOCKINSIGHT69
STOCKINSIGHT69 Apr. 18 at 12:03 PM
I called $HOOD early as a high-upside play — still tracking, but I’m always hunting for the next asymmetric setup. Current watchlist (high risk / high reward focus): $KLRA → Clinical-stage biotech. Pure speculation here — “story still forming.” Low liquidity = position sizing is key. $AVEX → Oncology pipeline + upcoming data catalysts. Early structure reminds me of pre-move setups — watching closely. $NBIS → AI infra exposure. Strong narrative tailwind, but margins + competition will decide if this re-rates. HIMS → Telehealth + consumer brand. Solid subscription model, but not cheap anymore. More swing/position trade vs breakout. ONDS → Defense + drone tech. Volatile, headline-driven — can move FAST both ways. This is not about certainty — it’s about risk/reward and timing. I’m lining up my next potential 10x candidate — will share soon. Stay selective. The market rewards positioning, not chasing.
1 · Reply
AngelosProject
AngelosProject Apr. 20 at 10:27 PM
0 · Reply
AngelosProject
AngelosProject Apr. 20 at 8:31 PM
0 · Reply
MorganHoratio
MorganHoratio Apr. 18 at 12:31 PM
$KLRA: Clinical‑stage biopharma, speculative “unwritten story,” but liquidity is a risk. $AVEX: Cancer drug developer with upcoming data readouts — early pattern looks like HOOD. $NBIS: AI infrastructure play, strong narrative but fierce competition — watch for margin bottom. $HIMS: Telehealth + consumer brand, stable subs, but valuation is no longer cheap — more mid‑term hold. $ONDS: Radar/communication + defense/drone, highly volatile, event‑driven.
4 · Reply
NasdaqPulse
NasdaqPulse Apr. 18 at 12:20 PM
I called $HOOD early as the next big momentum play — and I’m not slowing down. Still scanning for asymmetric setups with real upside. 👉Click to view @NasdaqPulse for timely updates amid the volatility. Here’s what’s on my radar right now: $KLRA — clinical-stage biotech, low float, high speculation. Story not priced in yet, but liquidity = risk. $AVEX — oncology pipeline + upcoming catalysts. Tape starting to resemble early $HOOD-type accumulation. $NBIS — AI infra theme still hot. Strong narrative, but margins + competition = key variables. Watching closely. HIMS — clean execution, strong subs growth. Not cheap anymore → more of a swing/position trade. ONDS — defense + drone tech. Violent moves, pure event-driven name. I’m hunting for the next 5–10x before the crowd sees it. One name is standing out — will drop it soon. Stay early or stay chasing.
0 · Reply
STOCKINSIGHT69
STOCKINSIGHT69 Apr. 18 at 12:03 PM
I called $HOOD early as a high-upside play — still tracking, but I’m always hunting for the next asymmetric setup. Current watchlist (high risk / high reward focus): $KLRA → Clinical-stage biotech. Pure speculation here — “story still forming.” Low liquidity = position sizing is key. $AVEX → Oncology pipeline + upcoming data catalysts. Early structure reminds me of pre-move setups — watching closely. $NBIS → AI infra exposure. Strong narrative tailwind, but margins + competition will decide if this re-rates. HIMS → Telehealth + consumer brand. Solid subscription model, but not cheap anymore. More swing/position trade vs breakout. ONDS → Defense + drone tech. Volatile, headline-driven — can move FAST both ways. This is not about certainty — it’s about risk/reward and timing. I’m lining up my next potential 10x candidate — will share soon. Stay selective. The market rewards positioning, not chasing.
1 · Reply